Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.12
-0.04 (-0.37%)
Jul 11, 2025, 9:30 AM - Market open
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.25 billion as of July 11, 2025. Its market cap has decreased by -47.97% in one year.
Market Cap
1.25B
Enterprise Value
671.73M
1-Year Change
-47.97%
Ranking
Category
Stock Price
$12.12
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.25B, an increase of 65.67%. That is a compound annual growth rate of 5.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 1.26B | 6.06% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.30B |
| Johnson & Johnson | 379.12B |
| AbbVie | 345.76B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 273.50B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.49B |
| AstraZeneca | 218.25B |